| Literature DB >> 34992714 |
Rajib Hossain1, Cristina Quispe2, Jesús Herrera-Bravo3,4, Md Shahazul Islam1, Chandan Sarkar1, Muhammad Torequl Islam1, Miquel Martorell5,6, Natália Cruz-Martins7,8,9,10, Ahmed Al-Harrasi11, Ahmed Al-Rawahi11, Javad Sharifi-Rad12, Manshuk Ibrayeva13, Sevgi Durna Daştan14,15, Mohammed M Alshehri16, Daniela Calina17, William C Cho18.
Abstract
Lasia spinosa (L.) is used ethnobotanically for the treatment of various diseases, including rheumatoid arthritis, inflammation of the lungs, bleeding cough, hemorrhoids, intestinal diseases, stomach pain, and uterine cancer. This review is aimed at summarizing phytochemistry and pharmacological data with their molecular mechanisms of action. A search was performed in databases such as PubMed, Science Direct, and Google Scholar using the keywords: "Lasia spinosa," then combined with "ethnopharmacological use," "phytochemistry," and "pharmacological activity." This updated review included studies with in vitro, ex vivo, and in vivo experiments with compounds of known concentration and highlighted pharmacological mechanisms. The research results showed that L. spinosa contains many important nutritional and phytochemical components such as alkanes, aldehydes, alkaloids, carotenoids, flavonoids, fatty acids, ketones, lignans, phenolics, terpenoids, steroids, and volatile oil with excellent bioactivity. The importance of this review lies in the fact that scientific pharmacological evidence supports the fact that the plant has antioxidant, anti-inflammatory, antimicrobial, cytotoxic, antidiarrheal, antihelminthic, antidiabetic, antihyperlipidemic, and antinociceptive effects, while protecting the gastrointestinal system and reproductive. Regarding future toxicological and safety data, more research is needed, including studies on human subjects. In light of these data, L. spinosa can be considered a medicinal plant with effective bioactives for the adjuvant treatment of various diseases in humans.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34992714 PMCID: PMC8727140 DOI: 10.1155/2021/1602437
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Amounts of micronutrients of Lasia spinosa in ppm (parts per million) [2].
| Elements | Amounts (ppm) |
|---|---|
| Zn | 7.442 ± 0.01 |
| Mg | 6.228 ± 0.11 |
| Fe | 17.06 ± 0.87 |
| Cu | 0.316 ± 0.02 |
| Mn | 1.334 ± 0.08 |
| Mo | 1.180 ± 0.06 |
Phytochemical profile of Lasia spinosa.
| Plant parts | Phytochemical class | Compounds | Ref. |
|---|---|---|---|
| Leave | Alkaloids | Berberine | [ |
|
| |||
| Leaf and root/rhizome | Aldehyde |
| [ |
| Other compounds | 4-Hydroxybenzoic acid, 2-(4′-methoxyphenyl)-ethanol, 4-methoxyphenethyl alcohol, 1-tetracosane | ||
|
| |||
| Stem | Carotenoid |
| [ |
|
| |||
| Aerial parts | Terpinoid | Limonene, | [ |
| Volatile oil | Methyl octadec-6,9-dien-12-ynoate, | [ | |
| Phenolics | 4-Hydroxybenzoic acid, morin, cinnamic acid, syringic acid, gentisic acid | Rahman et al., [ | |
| Fatty acids | Methyl ester of oleic acid, palmitic acid, stearic acid, epoxyoleic acid | Rahman et al., [ | |
| Steroid | Spinasterone, | Rahman et al., [ | |
| Alkane | Hexatriacontane, heptacosane | Rahman et al., [ | |
|
| |||
| Root/rhizome | Lignan | Lyoniresinol, meridinol, secoisolariciresinol; 5,5′-dimethoxysecoiso-lariciresinol; 2-(4-hydroxy-3,5-dimethoxybenzyl)-3-(4-hydroxy-3-methoxybenzyl)-1,2-butanediol; (7′S,8S,8R)-4,4′-dihydroxy-3,3′5,5′-tetramethoxy-7′,9-eproxylignan-9′-ol-7-one; 5,5′-dimethoxy-lariciresinol; 5′-methyoxlariciresinol, dihydrodehydrodiconifery alcohol; syringaresinol | Alam et al., [ |
| Phenolic | Procyanidin A1 | [ | |
|
| |||
| Whole plant | Phenolic | Gentisic acid, isovanilic acid, syringic acid, chlorogenic acid, p-hydroxy benzoic acid, (+)-catechin | [ |
| Flavonoids (glycosides and aglycones) | Vitexin, vitexin 2”-O- | [ | |
| Ketone | Hexahydrofarnesyl acetone | [ | |
Figure 1Chemical structures of the most important phytochemicals found in different parts of Lasia spinosa.
Figure 2Diagram with molecular mechanisms of anti-inflammatory effect of Lasia spinosa.
Pharmacological activities of Lasia spinosa.
| Activity | Sources | Test system | Dose tested | Positive value | Results | Ref. |
|---|---|---|---|---|---|---|
| Antioxidant | Ethyl acetate extract (leaves) | DPPH | IC50 = 73.20 | BHT | Moderate potential | [ |
| Ethanol extract (leaves) | DPPH | DPPH, | Vitamin C | ↑ antioxidant activity due to the presence of high levels of polyphenolic compounds | [ | |
| Hexane, chloroform, ethyl acetate, and methanol extracts (aerial parts) | DPPH | IC50 = 0.48 ± 0.04 | Not studied | ↑ antioxidant activity | [ | |
|
| ||||||
| Anti-inflammatory | Ethanol extract (leaves) | Lipopolysaccharide-induced RAW 264.7 macrophages | Dose = 50, 100, 200, 400 | L-NAME | ↑ NF- | [ |
| Hydroalcoholic extract (roots) | Carrageenan-induced paw edema model rats and xylene-induced ear edema mice | Dose = 250, 500 mg/kg bw, i.p. | Nalbuphine | ↓oedema formation | [ | |
|
| ||||||
| Antimicrobial | Methanol extract (leaves) | Disc diffusion assay | Dose = 400 | Kanamycin | Moderate antimicrobial activity against | [ |
| Hexane, chloroform, ethyl acetate, and methanol extracts (aerial parts) and essential oil | Disc diffusion assay | Dose = 300 | Tetracycline | Potent antibacterial activity against | [ | |
|
| ||||||
| Cytotoxicity | Hydromethanolic extract (leaves) | Brine shrimp lethality bioassay | LC50 = 98.663 | Vincristine sulphate | Moderate cytotoxic effect | [ |
| Methanol extract (whole plant) | Triton-X 100 (480 mg/kg, i.p.) induced hyperlipidemic rat model | IC50 = 13.49 | Vincristine sulphate | ↑cytotoxicity | [ | |
| Dose = 200, 400, 800 mg/kg, p.o. | Triton-X 100 | ↓triglycerides, ↓LDL-C | ||||
|
| ||||||
| Antidiarrheal | Hydroalcoholic extract (roots) | Castor oil-induced diarrhea mice model | 250 and 500 mg/kg b.w., i.p. | Loperamide | ↓number of stools | [ |
|
| ||||||
| Anthelmintic | Methanol extract (leaves) |
| Dose = 25, 50, 100 mg/mL, | Albendazole | ↑paralysis, ↑worm death, especially at 100 mg/ml | [ |
| Extract (leaves) |
| Dose = 200, 400, 800, 1600 mg/kg, p.o., | Praziquantel | ↓eggs per gram of feces | [ | |
|
| ||||||
| Antidiabetic | Hydroalcoholic extract (stem) | Dexamethasone 10 mg/kg s.c. induced diabetes rats | Dose = 200, 400 mg/kg, p.o. | Dexamethasone dose = 10 mg/kg | ↑antidiabetic activity | [ |
|
| ||||||
| Antihyperlipidemic | Methanol extract (leaves) | Cholestero,l 100 mg/kg p.o, induced hyperlipidemic rat model | Dose = 200, 400, 800 mg/kg, p.o. | Cholesterol | ↓cholesterol | [ |
| Triton-X 100, 480 mg/kg, i.p. induced hyperlipidemic rat model | Dose = 200, 400, 800 mg/kg, p.o. | Triton-X 100 | ↓triglycerides | |||
|
| ||||||
| Antinociceptive | Hydroalcoholic extract (roots) | Acetic acid-induced writhing and hot plate-induced pain in mice | Dose = 250, 500 mg/kg b.w., i.p. | Diclofenac sodium | 50% writhing inhibition | [ |
| Methanol extract (leaves) | Acetic acid writhing method and radiant heat tail flicking method | Dose = 200, 400 mg/kg, p.o. | Diclofenac sodium | ↓number of writhes ↑reaction time at dose 400 mg/kg | [ | |
|
| ||||||
| Gastroprotective | Ethanol extract (leaves) | Indomethacin, 5 mg/kg b.w., p.o. | Dose = 100, 200, 400 mg/kg, p.o. | Indomethacin dose = 5 mg/kg | Development of a defensive layer; ↑free radical scavenging activity; ↓LPO | [ |
|
| ||||||
| Reproductive activity | Hydroalcoholic extract (rhizomes) | Male rats | Dose = 5, 10, 20, 40 g/kg b.w., p.o. | Distilled water | ↑serum testosterone | [ |
Abbreviations: ABTS: 2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid; BHT: butylatedhydroxytoluene; DPPH: 1,1-diphenyl-2-pecrylhydrazyl; HO-1: heme-oxygenase-1; L-NAME: N-Nitro-L-arginine methyl ester; LDL-C: low-density lipoprotein cholesterol; MAPK: mitogen-activated protein kinase; NF-κB: kappa B; Nrf2: nuclear factor erythroid 2-related factor 2; PI3K/Akt: phosphoinositide-3-kinase/protein kinase B; VLDL-C: very-low-density lipoprotein cholesterol.
Figure 3Summarized scheme with traditional uses and the most representative biological properties of L. spinosa.